Cargando…

Novel and traditional lipid-related biomarkers and their combinations in predicting coronary severity

We investigated simultaneously traditional and novel lipid indices, alone or in combination, in predicting coronary severity assessed by Gensini score (GS) in 1605 non-lipid-lowering-drug-treated patients undergoing coronary angiography. Firstly, levels of triglycerides (TG), total cholesterol (TC),...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Sha, Guo, Yuan-Lin, Zhao, Xi, Zhang, Yan, Zhu, Cheng-Gang, Wu, Na-Qiong, Xu, Rui-Xia, Qing, Ping, Gao, Ying, Li, Xiao-Lin, Sun, Jing, Liu, Geng, Dong, Qian, Li, Jian-Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428477/ https://www.ncbi.nlm.nih.gov/pubmed/28336922 http://dx.doi.org/10.1038/s41598-017-00499-9

Ejemplares similares

Novel circulating lipid measurements for current dyslipidemias in non-treated patients undergoing coronary angiography: PCSK9, apoC3 and sdLDL-C
por: Li, Sha, et al.
Publicado: (2016)

Proprotein Convertase Subtilisin/Kexin type 9, C-Reactive Protein, Coronary Severity, and Outcomes in Patients With Stable Coronary Artery Disease: A Prospective Observational Cohort Study
por: Li, Jian-Jun, et al.
Publicado: (2015)

Risk Factors, Coronary Severity, Outcome and ABO Blood Group: A Large Chinese Han Cohort Study
por: Zhang, Yan, et al.
Publicado: (2015)

Large HDL Subfraction But Not HDL-C Is Closely Linked With Risk Factors, Coronary Severity and Outcomes in a Cohort of Nontreated Patients With Stable Coronary Artery Disease: A Prospective Observational Study
por: Li, Jian-Jun, et al.
Publicado: (2016)

Relationship of lipid and lipoprotein ratios with coronary severity in patients with new on-set coronary artery disease complicated with type 2 diabetics
por: Du, Ying, et al.
Publicado: (2016)

Association of Big Endothelin-1 with Coronary Artery Calcification
por: Qing, Ping, et al.
Publicado: (2015)

Impact of admission triglyceride for early outcome in diabetic patients with stable coronary artery disease
por: Li, Xiao-Lin, et al.
Publicado: (2014)

Free triiodothyronine in relation to coronary severity at different ages: Gensini score assessment in 4206 euthyroid patients
por: Zhou, Bing-Yang, et al.
Publicado: (2016)

Glycosylated hemoglobin A1c as a marker predicting the severity of coronary artery disease and early outcome in patients with stable angina
por: Hong, Li-Feng, et al.
Publicado: (2014)

Relation of Leukocytes and Its Subsets Counts with the Severity of Stable Coronary Artery Disease in Patients with Diabetic Mellitus
por: Hong, Li-Feng, et al.
Publicado: (2014)

Relations of physical signs to genotype, lipid and inflammatory markers, coronary stenosis or calcification, and outcomes in patients with heterozygous familial hypercholesterolemia
por: Liu, Ming-Ming, et al.
Publicado: (2021)

Relationship of Glycated Hemoglobin Levels with Myocardial Injury following Elective Percutaneous Coronary Intervention in Patients with Type 2 Diabetes Mellitus
por: Li, Xiao-Lin, et al.
Publicado: (2014)

Association of Fibrinogen with Severity of Stable Coronary Artery Disease in Patients with Type 2 Diabetic Mellitus
por: Hong, Li-Feng, et al.
Publicado: (2014)

Association between fibrinogen level and the severity of coronary stenosis in 418 male patients with myocardial infarction younger than 35 years old
por: Gao, Xiong-Yi, et al.
Publicado: (2017)

Comparison of statin plus ezetimibe with double-dose statin on lipid profiles and inflammation markers
por: Wu, Na-Qiong, et al.
Publicado: (2018)

Higher Fibrinogen Level is Independently Linked with the Presence and Severity of New-Onset Coronary Atherosclerosis among Han Chinese Population
por: Zhang, Yan, et al.
Publicado: (2014)

Increased red cell distribution width in patients with slow coronary flow syndrome
por: Luo, Song-Hui, et al.
Publicado: (2013)

Systemic Inflammatory Markers Are Closely Associated with Atherogenic Lipoprotein Subfractions in Patients Undergoing Coronary Angiography
por: Zhang, Yan, et al.
Publicado: (2015)

Serum fibrinogen and cardiovascular events in Chinese patients with type 2 diabetes and stable coronary artery disease: a prospective observational study
por: Yang, Sheng-Hua, et al.
Publicado: (2017)

Circulating microRNAs as biomarkers for severe coronary artery disease
por: Zhang, Xuelin, et al.
Publicado: (2020)

Free fatty acids and cardiovascular outcome: a Chinese cohort study on stable coronary artery disease
por: Zhang, Hui-Wen, et al.
Publicado: (2017)

Relationship of High‐Density Lipoprotein Cholesterol With Periprocedural Myocardial Injury Following Elective Percutaneous Coronary Intervention in Patients With Low‐Density Lipoprotein Cholesterol Below 70 mg/dL
por: Li, Xiao‐Lin, et al.
Publicado: (2015)

Policosanol Attenuates Statin-Induced Increases in Serum Proprotein Convertase Subtilisin/Kexin Type 9 When Combined with Atorvastatin
por: Guo, Yuan-Lin, et al.
Publicado: (2014)

Novel findings in relation to multiple anti-atherosclerotic effects of XueZhiKang in humans
por: Xu, Rui-Xia, et al.
Publicado: (2017)

Distribution of High-Density Lipoprotein Subfractions and Hypertensive Status: A Cross-Sectional Study
por: Zhang, Yan, et al.
Publicado: (2015)

Familial hypercholesterolemia in very young myocardial infarction
por: Li, Sha, et al.
Publicado: (2018)

Relation of plasma PCSK9 levels to lipoprotein subfractions in patients with stable coronary artery disease
por: Xu, Rui-Xia, et al.
Publicado: (2014)

Association of diabetes mellitus with clinical outcomes in patients with different coronary artery stenosis
por: Zhang, Hui-Wen, et al.
Publicado: (2021)

Application of expanded genetic analysis in the diagnosis of familial hypercholesterolemia in patients with very early-onset coronary artery disease
por: Cao, Ye-Xuan, et al.
Publicado: (2018)

Prognostic utility of lipoprotein(a) combined with fibrinogen in patients with stable coronary artery disease: a prospective, large cohort study
por: Zhang, Yan, et al.
Publicado: (2020)

Lipoprotein(a) and Cardiovascular Outcomes in Patients With Coronary Artery Disease and Different Metabolic Phenotypes
por: Jin, Jing-Lu, et al.
Publicado: (2022)

Improvement of evaluation in Chinese patients with atherosclerotic cardiovascular disease using the very-high-risk refinement: a population-based study
por: Li, Sha, et al.
Publicado: (2021)

Clinical features of coronary artery ectasia in the elderly
por: Huang, Qiao-Juan, et al.
Publicado: (2014)

HDL subfractions and very early CAD: novel findings from untreated patients in a Chinese cohort
por: Zhang, Yan, et al.
Publicado: (2016)

Impact of Non-Alcoholic Fatty Liver Disease on Cardiovascular Outcomes in Patients With Stable Coronary Artery Disease: A Matched Case–Control Study
por: Liu, Hui-Hui, et al.
Publicado: (2019)

Synergistic effect of the commonest residual risk factors, remnant cholesterol, lipoprotein(a), and inflammation, on prognosis of statin-treated patients with chronic coronary syndrome
por: Liu, Hui-Hui, et al.
Publicado: (2022)

Circulating PCSK9 and cardiovascular events in FH patients with standard lipid-lowering therapy
por: Cao, Ye-Xuan, et al.
Publicado: (2019)

Impact of currently prescribed lipid-lowering drugs on plasma PCSK9 concentration: single or in combination study in rats
por: Zhang, Yan, et al.
Publicado: (2014)

Serum Lipids, Apolipoproteins, and Mortality among Coronary Artery Disease Patients
por: Ding, Ding, et al.
Publicado: (2014)

Comparison of Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement and Lipid-Lowering Therapy in the Patients With Coronary Artery Disease With Different Renal Functions
por: Zhang, Shuang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kgtd8gl08mfh175r8n5brug4ub